Genomic Risk Factors of Vincristine-Induced Peripheral Neuropathy

被引：0
作者：
Mufti, Kheireddin [1 ,2 ]
Cordova, Miguel [2 ,3 ]
Scott, Erika [1 ,2 ]
Trueman, Jessica [2 ,3 ]
Lovnicki, Jessica [2 ,3 ]
Loucks, Catrina [2 ,3 ,4 ]
Rassekh, Shahrad [2 ,5 ]
Ross, Colin [1 ,2 ,6 ]
Carleton, Bruce [1 ,2 ,3 ,7 ]
机构：
[1] Univ British Columbia, Fac Med, Dept Med Genet, Vancouver, BC, Canada
[2] British Columbia Childrens Hosp, Res Inst, Vancouver, BC, Canada
[3] Univ British Columbia, Fac Med, Dept Pediat, Div Translat Therapeut, Vancouver, BC, Canada
[4] Univ British Columbia, Fac Med, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC, Canada
[5] Univ British Columbia, Dept Pediat, Div Hematol Oncol & Bone Marrow Transplant, Fac Med, Vancouver, BC, Canada
[6] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada
[7] BC Childrens Hosp, Pharmaceut Outcomes Programme, Vancouver, BC, Canada
来源：
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY | 2024年 / 102卷 / 04期
关键词：
Vincristine; Neuropathy; Adverse Drug Reactions; Pharmacogenomic;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：7 / 7
页数：1
相关论文
共 50 条
  • [41] Vincristine-induced neuropathy in rat: electrophysiological and histological study
    Ja'afer, Feras M. H.
    Hamdan, Farqad B.
    Mohammed, Faiq H.
    EXPERIMENTAL BRAIN RESEARCH, 2006, 173 (02) : 334 - 345
  • [42] Use of pyridoxine and pyridostigmine in children with vincristine-induced neuropathy
    Akbayram, Sinan
    Akgun, Cihangir
    Dogan, Murat
    Sayin, Refah
    Caksen, Huseyin
    Oner, Ahmet Faik
    INDIAN JOURNAL OF PEDIATRICS, 2010, 77 (06) : 681 - 683
  • [43] Use of pyridoxine and pyridostigmine in children with vincristine-induced neuropathy
    Sinan Akbayram
    Cihangir Akgun
    Murat Doğan
    Refah Sayin
    Huseyin Caksen
    Ahmet Faik Oner
    The Indian Journal of Pediatrics, 2010, 77 : 681 - 683
  • [44] The investigation of therapeutic potential of oxytocin and liraglutide on vincristine-induced neuropathy in rats
    Erdogan, Mumin A.
    Taskiran, Emin
    Yigitturk, Gurkan
    Erbas, Oytun
    Taskiran, Dilek
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2020, 34 (01)
  • [45] The effect of thioctic acid on allodynia in a rat vincristine-induced neuropathy model
    Kahng, Jimin
    Kim, Tae Kwan
    Chung, Eun Yong
    Kim, Yee Suk
    Moon, Jeong Yeon
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2015, 43 (03) : 350 - 355
  • [46] Measuring vincristine-induced peripheral neuropathy in children with cancer: validation of the Dutch pediatric–modified Total Neuropathy Score
    S. M. Schouten
    M. E. van de Velde
    G. J. L. Kaspers
    L. B. Mokkink
    I. M. van der Sluis
    C. van den Bos
    A. Hartman
    F. C. H. Abbink
    M. H. van den Berg
    Supportive Care in Cancer, 2020, 28 : 2867 - 2873
  • [47] Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy in Children with Cancer: A Systematic Review and Meta-Analysis
    Uittenboogaard, Aniek
    Neutel, Celine L. G.
    Ket, Johannes C. F.
    Njuguna, Festus
    Huitema, Alwin D. R.
    Kaspers, Gertjan J. L.
    van de Velde, Mirjam E.
    CANCERS, 2022, 14 (03)
  • [48] NETAZEPIDE IS NEUROPROTECTIVE IN A MOUSE MODEL OF VINCRISTINE-INDUCED SENSORY NEUROPATHY
    Bernard, Amandine
    Bourthoumieu, Sylvie
    Boyce, Malcolm
    Rovini, Amandine
    Desmouliere, Alexis
    Richard, Laurence
    Sturtz, Franck
    Danigo, Aurore
    Demiot, Claire
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2022, 27 : S17 - S17
  • [49] Measuring vincristine-induced peripheral neuropathy in children with cancer: validation of the Dutch pediatric-modified Total Neuropathy Score
    Schouten, S. M.
    van de Velde, M. E.
    Kaspers, G. J. L.
    Mokkink, L. B.
    van der Sluis, I. M.
    van den Bos, C.
    Hartman, A.
    Abbink, F. C. H.
    van den Berg, M. H.
    SUPPORTIVE CARE IN CANCER, 2020, 28 (06) : 2867 - 2873
  • [50] Anti-allodynic effect of theoesberiven F in a vincristine-induced neuropathy model
    Bang, Seunguk
    Kim, Yee Suk
    Jeong, Sang Rok
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (02) : 799 - 803
12345